Business Trends– category –
-
PROTACs vs. Molecular Glues: Comparing Targeted Protein Degraders for Size and Permeability in Drug Selection
Drug Target Review UK Overview PROTACs and molecular glues represent two distinct strategies for targeted protein degradation, each with unique advantages and challenges. PROTACs are bifunctional molecules that recruit an E3 ligase to a ... -
siRNA Therapy Successfully Switches Off Harmful Genes: FDA-Approved Patisiran and Other Drugs for Hereditary Amyloidosis
Works in Progress Magazine UK Overview siRNA therapy is emerging as a promising treatment to slow or halt disease progression by temporarily silencing specific genes. For conditions like hereditary transthyretin amyloidosis, FDA-approved... -
Bispecific Antibodies Revolutionize Cancer Therapy: 15 FDA-Approved, Over 600 in Clinical Trials as T-Cell Engagers
BroadPharm USA Overview Bispecific antibodies (BsAbs) are engineered to simultaneously bind two different antigens or epitopes, offering superior disease target recognition and biological effect modulation compared to conventional monocl... -
Honda Inaugurates Solid-State Battery Cell Production Demo Line in Sakura R&D Facility, Targeting 2026 Launch
How-To Geek Japan Overview Honda has launched a demonstration production line for solid-state battery cells at its Sakura R&D facility, aiming for mass production to commence in 2026. This strategic move marks a critical step towards... -
QuantumScape CDO Sells Shares Valued at $197K to Fulfill RSU Tax Obligations
The Motley Fool USA Overview Mohit Singh, Chief Development Officer (CDO) of QuantumScape Corporation, sold 34,304 shares of Class A common stock on August 18, 2026. This transaction, valued at approximately $197,000, was conducted to co... -
QuantumScape CEO Divests 80,000 Shares to Cover RSU-Related Tax Obligations
The Motley Fool USA Overview Srinivasan Sivaram, CEO of QuantumScape Corporation, disposed of 81,752 shares of Class A common stock on August 18, 2026. This transaction was solely to cover withholding tax obligations arising from the ves... -
QuantumScape Co-Founder & CTO Sells Entire Trust Holdings: Pre-Arranged Trading Plan Executed
The Motley Fool USA Overview Timothy Holme, Co-Founder and CTO of QuantumScape Corporation, sold 12,723 shares of Class A common stock held by his trust on August 21, 2026. This transaction was executed under a Rule 10b5-1 trading plan a... -
Samsung SDI and Volkswagen Accelerate Solid-State Battery Development Towards 2027 Mass Production Targets
SoylentNews USA Overview Samsung SDI is operating pilot production lines for its oxide-based all-solid-state anode-less/lithium metal batteries, developed in collaboration with BMW, targeting mass production by 2027. Concurrently, Volksw... -
China’s Leading Battery Makers Target 2027 Solid-State Battery Trial Production, Intensifying Race with BYD and CATL
Car News China China Overview Several major Chinese battery manufacturers are intensifying their efforts to achieve trial production of all-solid-state batteries by 2027. Dreame Technology has announced the most aggressive timeline, aimi... -
Geely Accelerates 500 Wh/kg Solid-State Battery Road Tests, Targeting 2027 EV Pilot Deployment
DigitalToday South Korea Overview Geely Auto has commenced road testing for its next-generation 500 Wh/kg solid-state batteries, aiming for pilot deployment in key EV models by 2027. These advanced batteries target over 1,000 km range pe...
